Teladoc Health, Inc. reports

Company location: New York, NY
Fiscal year end: 31 December

Teladoc Health, Inc. has filed 1,582 SEC EDGAR filings since 24 Nov 2009

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page

25

Current page

34

SC 13G/A File 005-89259

SCHEDULE 13G/A

Filing date: 10 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89259

SC 13G/A filing

Filing date: 05 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 04 Feb 2021
Reporting date: 03 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 04 Feb 2021
Reporting date: 02 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 -

Filing date: 03 Feb 2021
Reporting date: 28 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37477

FORM 8-K

Filing date: 29 Jan 2021
Reporting date: 28 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 -

Filing date: 27 Jan 2021
Reporting date: 25 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 25 Jan 2021
Reporting date: 22 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Jan 2021
Reporting date: 20 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 19 Jan 2021
Reporting date: 14 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 19 Jan 2021
Reporting date: 14 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 19 Jan 2021
Reporting date: 14 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 12 Jan 2021
Reporting date: 11 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37477

FORM 8-K

Filing date: 11 Jan 2021
Reporting date: 11 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 -

Filing date: 07 Jan 2021
Reporting date: 06 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 06 Jan 2021
Reporting date: 05 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 06 Jan 2021
Reporting date: 04 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 06 Jan 2021
Reporting date: 04 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-89259

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date: 21 Dec 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 16 Dec 2020
Reporting date: 14 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 11 Dec 2020
Reporting date: 10 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 10 Dec 2020
Reporting date: 08 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .